Geneos Wealth Management Inc. Bausch Health Companies Inc. Transaction History

Geneos Wealth Management Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$7.77 - $10.61 $505 - $689	65 New	65 $0
Q3 2022 Nov 14, 2022	SELL	$4.58 - $9.21 $879 - $1,768	-192 Reduced 35.04%	356 $2,000
Q4 2021 Feb 09, 2022	SELL	$23.0 - $29.01 $1,150 - $1,450	-50 Reduced 8.36%	548 $15,000
Q2 2021 Jul 08, 2021	BUY	$27.43 - $32.7 $1,371 - $1,635	50 Added 9.12%	598 $17,000
Q4 2020 May 19, 2021	SELL	$15.31 - $21.12 $8,420 - $11,616	-550 Reduced 50.09%	548 $16,000
Q3 2020 Sep 07, 2021	SELL	$14.88 - $20.13 $7,440 - $10,065	-500 Reduced 31.29%	1,098 $16,000
Q1 2020 Sep 07, 2021	SELL	$12.98 - $30.25 $2,037 - $4,749	-157 Reduced 8.95%	1,598 $23,000
Q3 2019 Sep 07, 2021	BUY	$20.88 - $25.66 $751 - $923	36 Added 2.09%	1,755 $38,000
Q2 2019 Sep 07, 2021	SELL	$20.52 - $26.45 $3,078 - $3,967	-150 Reduced 8.03%	1,719 $43,000
Q4 2018 Sep 07, 2021	SELL	$17.64 - $28.32 $9,596 - $15,406	-544 Reduced 22.54%	1,869 $35,000
Q3 2018 Sep 07, 2021	BUY	$20.64 - $25.67 $49,804 - $61,941	2,413 New	2,413 $61,000

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

Stay updated on Geneos Wealth Management Inc. with notifications on news.